Journal Article

Persistence of Nevirapine in Breast Milk after Discontinuation of Treatment

Chantelle Bennetto-Hood, Grace M. Aldrovandi, Jennifer R. King, Kyra Woodman, Negar Ashouri and Edward P. Acosta

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 45, issue 3, pages 391-394
Published in print August 2007 | ISSN: 1058-4838
Published online August 2007 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/519427
Persistence of Nevirapine in Breast Milk after Discontinuation of Treatment

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

The objective of this study was to serially quantitate the concentration of nevirapine in breast milk after discontinuation of treatment. Samples were collected from both breasts of a human immunodeficiency virus–infected patient for 3 weeks. Nevirapine was quantifiable for up to 17 days after discontinuation of therapy; total nevirapine concentrations remained above the 90% inhibitory concentration for 6 days, and no differences were observed between breasts.

Journal Article.  2404 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.